secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtriCure, Inc. (ATRC)
CIK:        0001323885
Form:       8-K
Filed at:   2025-10-29T23:59:59+00:00
Accession:  0001323885-25-000098
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AtriCure Q3 revenue +15.8% to $134.3M, net loss narrows to $0.3M; raises 2025 outlook
--------------------------------------------------------------------------------

- Revenue of $134.3M (+15.8% YoY); U.S. $109.3M (+14.5%), international $25.0M (+22.0%).
- Net loss of $0.3M ($0.01 diluted EPS) improves $7.6M YoY; adjusted EBITDA $17.8M (+$9.9M).
- Gross margin 75.5% (+59 bps) on favorable product mix; operating income $0.2M vs loss of $7.4M.
- Company raises full-year 2025 financial outlook (specific guidance numbers not disclosed in press release).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1323885/000132388525000098/0001323885-25-000098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1323885/000132388525000098/atrc-20251029.htm
  HTML page:      https://secwatch.observer/filing/0001323885-25-000098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer